tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

WINT Stock Latest News

Windtree Therapeutics Secures $500M Equity Line for Crypto
Company AnnouncementsWindtree Therapeutics Secures $500M Equity Line for Crypto
1d ago
8K
WINT
Windtree enters into common stock purchase agreement for up to $500M
PremiumThe Fly
Windtree enters into common stock purchase agreement for up to $500M
1d ago
WINT
Windtree Therapeutics, Kraken announce strategic partnership
PremiumThe Fly
Windtree Therapeutics, Kraken announce strategic partnership
3d ago
WINT
Windtree Therapeutics Announces $60M Securities Agreement
PremiumCompany Announcements
Windtree Therapeutics Announces $60M Securities Agreement
8d ago
8K
WINT
Windtree Therapeutics to launch BNB crypto treasury strategy
PremiumThe Fly
Windtree Therapeutics to launch BNB crypto treasury strategy
9d ago
WINT
Windtree Therapeutics Issues Convertible Promissory Notes
PremiumCompany AnnouncementsWindtree Therapeutics Issues Convertible Promissory Notes
22d ago
8K
WINT
Windtree Therapeutics announces issuance of istaroxime patent for U.S.
Premium
The Fly
Windtree Therapeutics announces issuance of istaroxime patent for U.S.
23d ago
WINT
Windtree announces istaroxime Phase 2 study hit enrollment target
Premium
The Fly
Windtree announces istaroxime Phase 2 study hit enrollment target
25d ago
WINT
Windtree Therapeutics CFO Resignation and Leadership Shift
PremiumCompany Announcements
Windtree Therapeutics CFO Resignation and Leadership Shift
28d ago
8K
WINT
Windtree Therapeutics Receives Nasdaq Deficiency Letter
PremiumCompany Announcements
Windtree Therapeutics Receives Nasdaq Deficiency Letter
1M ago
8K
WINT
Windtree Therapeutics announces istaroxime Phase 2 study called SEISMiC B
PremiumThe Fly
Windtree Therapeutics announces istaroxime Phase 2 study called SEISMiC B
1M ago
WINT
Windtree Therapeutics Raises $3.9M Through Note Agreements
PremiumCompany Announcements
Windtree Therapeutics Raises $3.9M Through Note Agreements
1M ago
8K
WINT
Windtree Therapeutics receives offer for preclinical oncology drug candidate
PremiumThe FlyWindtree Therapeutics receives offer for preclinical oncology drug candidate
1M ago
WINT
Windtree Therapeutics announces agreement to acquire Titan Environmental
Premium
The Fly
Windtree Therapeutics announces agreement to acquire Titan Environmental
2M ago
WINT
Windtree Therapeutics announces plan for cryptocurrency treasury policy
Premium
The Fly
Windtree Therapeutics announces plan for cryptocurrency treasury policy
2M ago
WINT
Windtree says interim results for SEISMiC SCAI Stage C study set for July 2025
PremiumThe Fly
Windtree says interim results for SEISMiC SCAI Stage C study set for July 2025
2M ago
WINT
Windtree Therapeutics Inc. Reports Q1 2025 Financial Results
PremiumCompany Announcements
Windtree Therapeutics Inc. Reports Q1 2025 Financial Results
2M ago
WINT
Windtree Therapeutics files to sell 42.17M shares of common stock for holders
PremiumThe Fly
Windtree Therapeutics files to sell 42.17M shares of common stock for holders
2M ago
WINT
Windtree Therapeutics reports Q1 EPS ($4.63)
PremiumThe Fly
Windtree Therapeutics reports Q1 EPS ($4.63)
2M ago
WINT
Windtree Therapeutics announces presentation highlighting istaroxime
PremiumThe FlyWindtree Therapeutics announces presentation highlighting istaroxime
2M ago
WINT
Windtree receives advice from IP, FDA on exclusivity strategy for istaroxime
Premium
The Fly
Windtree receives advice from IP, FDA on exclusivity strategy for istaroxime
3M ago
WINT
Windtree Therapeutics enters Assignment, Conditional Assumption Agreement
Premium
The Fly
Windtree Therapeutics enters Assignment, Conditional Assumption Agreement
3M ago
WINT

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >